您的位置: 首页 > 农业专利 > 详情页

Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy
专利权人:
Regeneron Pharmaceuticals, Inc;Sanofi Biotechnology;Regeneron Pharmaceuticals; Inc
发明人:
Pordy, Robert C.,Sasiela, William J.,Harp, Joyce B.,Hanotin, Corinne,Bessac, Laurence
申请号:
AU2015217118
公开号:
AU2015217118A1
申请日:
2015.02.12
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present invention provides methods for treating hypercholesterolemia. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P. The methods of the present invention are useful for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充